A new pancreatic cancer drug that has shown it can nearly double patient survival time is hitting the market with a price tag of approximately $483,990 a year, reflecting the rise in cancer treatment costs.
Continue reading...
[ H/T Newsmax ]
Headlines
$483K a Year for New Pancreatic Drug
- Author Conservative Angle
- Published Published
- 1 min read
A new pancreatic cancer drug that has shown it can nearly double patient survival time is hitting the market with a price tag of approximately $483,990 a year, reflecting the rise in cancer treatment costs.
Continue reading...
[ H/T Newsmax ]
